Diabetes drug tested as potential kidney protector
NCT ID NCT07302464
Summary
This study aimed to see if a type of diabetes medication (SGLT2 inhibitors) could help protect kidney function in people with chronic kidney disease, whether they had diabetes or not. Researchers compared changes in a key measure of kidney health (eGFR) in 60 adult participants with moderate to advanced kidney disease. The goal was to understand if this drug's benefits extend beyond blood sugar control to directly help the kidneys.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, 11591, Egypt
Conditions
Explore the condition pages connected to this study.